对比
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 vs 3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
两者均为慢性病，但系统与严重程度不同：前者是累及脑、听力和能量代谢的严重线粒体疾病；后者是可能影响性发育的中度内分泌激素处理障碍。确切结局尚未确立。
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
A severe mitochondrial disorder affecting the brain, hearing, and energy metabolism. It causes progressive neurological decline, hearing loss, and metabolic problems. Management requires intensive supportive care.
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
A rare condition affecting how certain hormones are processed in the body, which can influence sexual development. Treatment may involve hormone therapy and specialist care.
6 个对比维度
Onset
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
0-5
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
0-16
Onset patterns differ
Severity
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
severe
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
Chronic
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
No
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
No
Different transmission
Body System
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
metabolic
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
endocrine
Same/different system
Category
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
metabolic
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
endocrine
Different category
结论
3-methylglutaconic-aciduria-with-deafness-encephalopathy-and-leigh-like-syndrome-C4040739 and 3-oxo-5-alpha-steroid-delta-4-dehydrogenase-deficiency-C0268297 differ in severity, etiology
关键鉴别要点
在床旁或检查过程中最能可靠区分两种疾病的发现。
| 特征 | 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 | 3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297 | 鉴别力 |
|---|---|---|---|
| 神经病程 | 描述为进行性神经功能下降和脑病。 | 来源未描述原发性脑病。 | High |
| 听力 | 听力损失是所述核心表现。 | 来源未将其列为特征。 | High |
| 性发育 | 性发育不是所述主要问题。 | 激素处理异常可能影响性发育。 | Moderate |
何时更支持某种疾病
选择 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 的情况
早期进行性脑和听力受累
更符合所述严重线粒体疾病模式。
Moderate
伴神经下降的代谢失代偿
来源明确描述能量代谢受累。
Moderate
Leigh样临床表现
名称和描述明确包含Leigh样特征。
High
选择 3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297 的情况
无脑病的非典型性发育
来源重点是激素处理与性发育。
Moderate
以内分泌评估为主要问题
该病归类为内分泌而非线粒体疾病。
Moderate
中度慢性病程且无听力损失
严重程度为中度，未描述听力受累。
Low
关键检查差异
| 检查 | 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 | 3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297 | 解读 |
|---|---|---|---|
| 尿有机酸分析 | 可寻找3-甲基戊烯二酸升高；界值未提供。 | 来源未确立有机酸异常。 | 异常结果支持进一步代谢评估，但本身不是诊断。 |
| 听力评估和神经影像 | 可检查听力损失和脑部受累。 | 根据现有描述并非核心检查。 | 结果需临床关联；具体影像模式尚未确立。 |
| 类固醇激素谱和基因检测 | 不是所述主要评估。 | 可考虑激素检查和专科基因检测。 | 激素异常提示内分泌疾病，但不能单独确诊。 |
预后对比
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
- 转归
- 描述为严重，伴进行性神经和代谢问题；确切生存情况未确立。
- 因素
- 脑、听力和代谢受累程度可能影响需求。
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
- 转归
- 描述为中度慢性；个体结局未确立。
- 因素
- 激素影响及对专科治疗的反应可能重要。
时间范围: 两者均为慢性；左侧起病列为0–5岁，右侧为0–16岁。
预后应个体化；未提供比较性结局数据。
并发症对比
| 并发症 | 表现 |
|---|---|
| 神经功能恶化 | 描述为进行性下降，可能需强化支持。 未被描述为主要并发症。 程度和时间尚不能由这些数据确定。 |
| 听力损害 | 明确描述有听力损失。 来源描述未提及。 程度、侧别和进展未说明。 |
| 性发育异常 | 不是所述主要特征。 可能由激素处理异常引起。 个体表现不同，需专科判断。 |
患者教育要点
- High疾病类别不同
前者主要累及线粒体、脑和听力；后者涉及激素处理与发育。
- High专科照护
应由代谢、神经、听力或内分泌专科指导检查和治疗。
- Medium信息局限
本摘要不能确定确切风险、检验界值、治疗或结局。